| 22.71 -0.87 (-3.69%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 35.13 | 1-year : | 41.58 |
| Resists | First : | 30.08 | Second : | 35.59 |
| Pivot price | 26.1 |
|||
| Supports | First : | 21.15 | Second : | 17.6 |
| MAs | MA(5) : | 22.83  |
MA(20) : | 27.62 |
| MA(100) : | 23.93 |
MA(250) : | 37.15 |
|
| MACD | MACD : | -2 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 16.8 |
D(3) : | 14.9 |
| RSI | RSI(14): 35.6 |
|||
| 52-week | High : | 74.06 | Low : | 11.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CTEV ] has closed above bottom band by 25.3%. Bollinger Bands are 49.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 24.57 - 24.69 | 24.69 - 24.77 |
| Low: | 22.37 - 22.53 | 22.53 - 22.63 |
| Close: | 22.49 - 22.72 | 22.72 - 22.87 |
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Thu, 30 Jul 2026
Claritev leads non-payer organizations in federal dispute volume By Investing.com - Investing.com Nigeria
Thu, 30 Jul 2026
Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels - Yahoo Finance
Thu, 30 Jul 2026
CTEV|Claritev Corp|Price:23.178|Chg%:-0.402 - TradingKey
Tue, 28 Jul 2026
Claritev™ and SAVVI Financial® Collaborate to Deliver the Next Generation of Healthcare Benefit Decision Support - TradingView
Tue, 28 Jul 2026
Claritev's New Solution Turns Healthcare Claims Into Plan Guidance - Stock Titan
Fri, 24 Jul 2026
Claritev Corporation (CTEV) Stock Analysis: Exceptional Growth Potential with a 61.87% Upside - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 17 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 7.4 (%) |
| Held by Institutions | 90.8 (%) |
| Shares Short | 987 (K) |
| Shares Short P.Month | 1,140 (K) |
| EPS | -17.33 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -14.19 |
| Profit Margin | -29.3 % |
| Operating Margin | 7.5 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 5.8 % |
| Gross Profit (p.s.) | 42.03 |
| Sales Per Share | 57.4 |
| EBITDA (p.s.) | 31.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 102 (M) |
| Levered Free Cash Flow | 109 (M) |
| PE Ratio | -1.32 |
| PEG Ratio | 0 |
| Price to Book value | -1.61 |
| Price to Sales | 0.39 |
| Price to Cash Flow | 3.81 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|